Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B12 plus calcium levofolinate add-on therapy with interferon beta in relapsing-remitting multiple sclerosis
2005-006071-12Phase 3Completed
- Sponsor
- San Camillo-Forlanini
- Start
- May 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cyanocobalamin, levoleucovorin and interferon beta-1a in multiple sclerosis (MS) (2 arms), sponsored by San Camillo-Forlanini. Primary endpoint: Rate of brain atrophy on MRI over 24 months. Started May 2006; status: completed.
02
Drugs
cyanocobalaminlevoleucovorininterferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-006071-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006071-12.